U.S. teaching hospitals care for the tiniest hearts

Innovations-tiniest-hearts-992x558px.jpg

With few American families untouched by heart disease, the last decade has witnessed remarkable advances in the diagnosis and treatment of infant congenital heart defects (CHDs). 

Medical schools and teaching hospitals across the United States have been at the forefront of innovative diagnostic procedures and groundbreaking therapies. CHDs impact approximately 40,000 babies each year, with an estimated 25% critical enough to require surgical or other interventions soon after birth. 

Wednesday, December 05, 2018

Teaching hospital therapeutic breakthroughs in neonatal cardiology

  • Therapeutic catheterization procedures 
  • Open heart surgery
  • Fetal surgery/therapies
  • Heart transplants
  • Extra corporeal membrane oxygenation (ECMO)

Today, families that once faced losing their babies, instead increasingly have options for life-saving and quality-of-life improving interventions found in teaching hospitals.

Remarkable advances have taken place in the safety and effectiveness of diagnostic and therapeutic approaches to CHDs.

Teaching hospitals lead in early diagnosis and intervention

States that have mandates for early screening for CHDs, coupled with advanced interventions, have experienced a 33.4% decrease in death rates, compared to states without such policies. 

Leaders from teaching hospitals across the country have promoted universal screening for CHDs, leading to the federal government and 48 states adopting screening standards by 2016. In addition, leaders in academic medicine, collaborating in a collective workgroup, are continuing the effort to ensure that more effective screenings are available through research and training of health care providers. 

Specialized health care providers using innovative technology can vastly improve the outcomes for babies when the diagnosis comes shortly after delivery. In some cases, prenatal diagnoses may result in life-saving interventions before a baby leaves the womb.

That technology is found in facilities with the highest level neonatal and cardiac intensive care units and are equipped with life-sustaining interventions such as extra corporeal membrane oxygenation (ECMO), an advanced external heart/lung life support technique, and pediatric ventricular assist devices (VADs), mechanical devices designed to assist the heart in pumping and often used as a bridge to transplant or as a bridge to recovery.

These facilities— found almost exclusively at teaching hospitals —provide 24/7 access to the most advances services including anesthesiology, imaging, diagnostic and interventional cardiology, cardiac surgery. 

Innovation in the treatment of critical pediatric CHDs encompass a range of interventions that start during gestation. One of those interventions is advanced prenatal imaging.

Advanced prenatal imaging

Researchers from Yale Medical School were part of the first group to demonstrate fetal cardiac imaging and to support universal screening for CHDs. Today, academic medicine is helping advance the accuracy of fetal imaging techniques while working to lower radiation exposure. As a result, using state-the-art techniques, prenatal (before birth) and postnatal (after delivery) diagnoses agree upwards of 90% of the time and some CHDs may be screened as early as 12 weeks of gestation.1

In a 2014 scientific statement of the American Heart Association noted, “The diagnosis of cardiac disease in the fetus is mostly made with ultrasound; however, new technologies, including 3- and 4-dimensional echocardiography, magnetic resonance imaging, and fetal electrocardiography and magnetocardiography, are available. Medical and interventional treatments for select diseases and strategies for delivery room care enable stabilization of high-risk fetuses and contribute to improved outcomes."2

But even as imaging is increasingly the standard in prenatal care, some patients don’t have access to those services.

Telemedicine: Reaching the underserved

Health providers have found that reaching babies as early as possible with technology tools such as prenatal imaging leads the best outcomes. Telemedicine has helped with that effort.

Thursday, December 06, 2018

Lifesaving pediatric heart care advances

  • Advanced Prenatal Imaging Techniques
  • Telemedicine
  • Neonatal Surgery and Interventional Cardiology
  • Pediatric Heart Transplantation

Telemedicine allows academic medical center services to reach babies and children in rural and underserved areas. Rural and outlying communities, with smaller, remote and geographically dispersed populations, often lack immediate access to these specialty physicians and services. 

Aided by telemedicine technology, however, many of America’s teaching hospitals are reaching out to local maternal-child health providers, and even directly to patients, to increase access to quality care, while minimizing the cost and inconvenience of traveling to a major center. 

Teaching hospitals such as Children’s Hospital of Pennsylvania (CHOP), Nationwide (OH), OHSU (OR), (Johns Hopkins (MD), University of Kansas Medical Center, Children’s Hospital Colorado, and Mott Children’s Hospital (MI) are but a few of the academic institutions offering fetal and pediatric telemedicine services to remote providers and their patients.

For example, tele-echocardiography allows a fetus or a newborn’s heart to be imaged in their local community and evaluated by specialists at a major teaching hospital.

Once a definitive diagnosis is made, then intervention, which sometimes can mean either a non-invasive procedure or surgery, can begin.

 

1. Bravo-valenzuela, NJ, Peixoto, AB, Arajo, E. Prenatal diagnosis of congenital heart disease: A review of current knowledge. Indian Heart Journal. 2018 Jan - Feb;70(1):150-164. doi: 10.1016/j.ihj.2017.12.005
2. Donofrio MT, Moon-Grady AJ, Hornberger LK, Copel JA, Sklansky MS, Abuhamad A, Cuneo BF, et al. Diagnosis and treatment of fetal cardiac disease: A scientific statement from the American Heart Association. Circulation. 2014;129(21):2183-2242. doi: 10.1161/01.cir.0000437597.44550.5d